🇺🇸 FDA
Pipeline program

Rasagiline

TVP-1012/PM106

Approved small_molecule active

Quick answer

Rasagiline for Parkinson's Disease is a Approved program (small_molecule) at Teva Pharma GmbH with 5 ClinicalTrials.gov record(s).

Program details

Company
Teva Pharma GmbH
Indication
Parkinson's Disease
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials